AU2819400A - Use of condensed 2,3-benzodiazepine derivatives for the treatment and prophylaxis of diseases related to the inhibition of lipid peroxidation - Google Patents

Use of condensed 2,3-benzodiazepine derivatives for the treatment and prophylaxis of diseases related to the inhibition of lipid peroxidation

Info

Publication number
AU2819400A
AU2819400A AU28194/00A AU2819400A AU2819400A AU 2819400 A AU2819400 A AU 2819400A AU 28194/00 A AU28194/00 A AU 28194/00A AU 2819400 A AU2819400 A AU 2819400A AU 2819400 A AU2819400 A AU 2819400A
Authority
AU
Australia
Prior art keywords
prophylaxis
condensed
inhibition
treatment
diseases related
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU28194/00A
Inventor
Laszlo Balazs
Jozsef Barkoczy
Imre Doman
Andras Egyed
Gabor Gigler
Zoltan Greff
Peter Kotay Nagy
Gyorgy Levay
Judit Raczne Bajnogel
Zoltan Ratkai
Geza Schneider
Peter Seres
Gyula Simig
Geza Szabo
Gabor Szenasi
Karoly Tihanyi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Egis Pharmaceuticals PLC
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Egis Pharmaceuticals PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar, Egis Pharmaceuticals PLC filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of AU2819400A publication Critical patent/AU2819400A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU28194/00A 1999-02-15 2000-02-15 Use of condensed 2,3-benzodiazepine derivatives for the treatment and prophylaxis of diseases related to the inhibition of lipid peroxidation Abandoned AU2819400A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HU9900354A HUP9900354A3 (en) 1999-02-15 1999-02-15 Use of condensed 2,3-benzodiazepine derivatives for the preparation of pharmaceutical compositions treating and preventing diseases related with the inhibition of lipide peroxidation
HU9900354 1999-02-15
PCT/HU2000/000011 WO2000053166A2 (en) 1999-02-15 2000-02-15 Use of condensed 2,3-benzodiazepine derivatives for the treatment and prophylaxis of diseases related to the inhibition of lipid peroxidation

Publications (1)

Publication Number Publication Date
AU2819400A true AU2819400A (en) 2000-09-28

Family

ID=89997786

Family Applications (1)

Application Number Title Priority Date Filing Date
AU28194/00A Abandoned AU2819400A (en) 1999-02-15 2000-02-15 Use of condensed 2,3-benzodiazepine derivatives for the treatment and prophylaxis of diseases related to the inhibition of lipid peroxidation

Country Status (3)

Country Link
AU (1) AU2819400A (en)
HU (1) HUP9900354A3 (en)
WO (1) WO2000053166A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201536795A (en) 2013-05-31 2015-10-01 Medeia Therapeutics Ltd Use of arylthiazine compounds as cytoprotectants

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU206719B (en) * 1990-12-21 1992-12-28 Gyogyszerkutato Intezet Process for producing 1-/4-acylamino-phenyl/-7,8-methylenedioxy-5h-2,3-benzodiazepine derivatives, acid addicional salts and pharmaceutical compositions containing them
US5519019A (en) * 1990-12-21 1996-05-21 Gyogyszerkutato Intezet N-acyl-2,3-benzoidazepine derivatives, pharmaceutical compositions containing them and process for preparing same
US5639751A (en) * 1990-12-21 1997-06-17 Cyogyszerkutato Intezet Kft N-acyl-2,3-benzodiazepine derivatives for treating acute and chronic neurodegenerative disorders
US6172043B1 (en) * 1997-01-10 2001-01-09 Massachusetts Institute Of Technology Treatments for neurotoxicity in Alzheimer's disease caused by β amyloid peptides
SK1792000A3 (en) * 1997-08-12 2000-09-12 Egyt Gyogyszervegyeszeti Gyar 1,3-DIOXOLO(4,5-H)(2,3)BENZODIAZEPINE DERIVATIVES, PROCESS FORì (54) THE PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION CO
UA67749C2 (en) * 1997-08-12 2004-07-15 Егіш Дьйодьсердьяр Рт. 8-substituted-9h-1,3-dioxolo-[4,5-h][2,3]benzodiazepine being inhibitors of the ampa/kainite receptor

Also Published As

Publication number Publication date
HUP9900354A3 (en) 2001-02-28
HU9900354D0 (en) 1999-04-28
WO2000053166A2 (en) 2000-09-14
HUP9900354A2 (en) 2001-01-29
WO2000053166A3 (en) 2000-12-21

Similar Documents

Publication Publication Date Title
AU2291001A (en) Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states
HK1037861A1 (en) Formulations for the prevention or the treatment of diseases affecting mucosae or skin, or for pregnancy prevention
AU2002213002A1 (en) Antisense inhibition of caspase 6 expression
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU1773600A (en) Topical treatment of skin disease
EP1440691A3 (en) Treatment of neurotic disorders
AU2001256855A1 (en) Preparation for the prevention and treatment of ocular disorders
AU2002220735A1 (en) Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain
HUP0104963A3 (en) Compositions for the treatment of skin diseases
HUP0203611A3 (en) 14,15-beta-methylene substituted androgens and their use for preparation of the medicaments
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU2670600A (en) Pharmaceutical composition containing desoxypeganine for the treatment of nicotine dependence
AU5729099A (en) Use of cyclopentabenzofuran-derivatives for combating nf-KappaB-dependent diseases
AU7106300A (en) Treatment of skin disorders
AU2002215187A1 (en) S-adenosylmethionine and derivatives thereof for the treatment and prevention ofalzheimer's disease
CA2260863A1 (en) Treatment of psychotic disorders
AU2819400A (en) Use of condensed 2,3-benzodiazepine derivatives for the treatment and prophylaxis of diseases related to the inhibition of lipid peroxidation
AU7653600A (en) Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives for the treatment of multiple sclerosis
AU3760900A (en) Treatment of menstrual function
AU2671101A (en) Regulation of human mitochondrial deformylase
AU1022501A (en) Use of compositions for the caring treatment of the skin
AU8553898A (en) Use of 2,3-benzodiazepine derivatives for the preparation of pharmaceutical compositions to treat diseases connected with the endogenous opioid system
AU2002221566A1 (en) Novel benzimidazole derivatives for the treatment of gaba-alpha mediated disorders
HUP0201610A2 (en) Derivatives of 4'-demycarosyl-8a-aza-8a-homotylosin

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase